CYNTHIA MARIA MAGRO
Medical Practice in New York, NY
License number
Pennsylvania MD067468L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
New York, NY 10065
Pennsylvania
Pennsylvania
Personal information
See more information about CYNTHIA MARIA MAGRO at radaris.comName
Address
Phone
120 Fort Salonga Rd, Northport, NY 11768
316 E Main St, Frankfort, NY 13340
44 E 65Th St APT 2B, New York, NY 10065
New York, NY
44 65Th St, Manhattan, NY 10021
Professional information
Dr. Cynthia Magro, New York NY - MD (Doctor of Medicine)
Specialties:
Dermatopathology, Cytopathology
Address:
New York Weill Cornell Medical Center
1300 York Ave SUITE F309, New York 10065
(212) 746-6434 (Phone)
525 E 68Th St, New York 10065
(646) 253-2808 (Phone), (212) 746-3856 (Fax)
1300 York Ave SUITE F309, New York 10065
(212) 746-6434 (Phone)
525 E 68Th St, New York 10065
(646) 253-2808 (Phone), (212) 746-3856 (Fax)
Certifications:
Anatomic Pathology, 1988, Cytopathology, 1991, Dermatopathology, 1990
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
New York Weill Cornell Medical Center
1300 York Ave SUITE F309, New York 10065
525 E 68Th St, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
NewYork-Presbyterian/Weill Cornell Medical Center
525 East 68Th St, New York 10065
1300 York Ave SUITE F309, New York 10065
525 E 68Th St, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
NewYork-Presbyterian/Weill Cornell Medical Center
525 East 68Th St, New York 10065
Education:
Medical School
University of Manitoba / Faculty of Medicine
U Manitoba Affil Tchg Hosps
Massachusetts General Hospital
University of Manitoba / Faculty of Medicine
U Manitoba Affil Tchg Hosps
Massachusetts General Hospital
Cynthia Magro, New York NY
Work:
NewYork-Presbyterian / Weill Cornell
525 E 68Th St, New York, NY 10065
525 E 68Th St, New York, NY 10065
Cynthia M Magro, New York NY
Specialties:
Pathologist
Address:
525 E 68Th St, New York, NY 10065
Method For Diagnosing Melanocytic Proliferations
US Patent:
2013006, Mar 14, 2013
Filed:
Apr 6, 2011
Appl. No.:
13/642475
Inventors:
Cynthia Magro - New York NY, US
Jonathan Zippin - New York NY, US
Lonny R. Levin - New York NY, US
Jochen Buck - Greenwich CT, US
Jonathan Zippin - New York NY, US
Lonny R. Levin - New York NY, US
Jochen Buck - Greenwich CT, US
Assignee:
CORNELL UNIVERSITY - Ithaca NY
International Classification:
G01N 33/574, G01N 33/577
US Classification:
435 74
Abstract:
The invention provides a method for diagnosing a melanocytic proliferation in a subject comprising staining a sample of lesional melanocytes with an antibody against soluble adenylyl cyclase (sAC) and interpreting the sAC staining pattern, which is associated with a diagnosis of a melanocytic proliferation. The sAC staining pattern, which is complex, is discriminatory and distinctive according to the nature of the melanocytic proliferation. The sAC staining pattern comprises one or more of dot-like Golgi staining, broad granular Golgi staining, diffuse cytoplasmic staining, nucleolar staining, incomplete granular nuclear staining, and pan-nuclear staining. The method of the invention is particularly useful in confirming or disaffirming a diagnosis reached through conventional histologic examination of a sample. Additionally, the invention provides a kit for use in interpreting melanocytic proliferations.
Methods And Compositions For Treating Degos' Disease
US Patent:
2013006, Mar 14, 2013
Filed:
Mar 1, 2011
Appl. No.:
13/582018
Inventors:
Cynthia Magro - New York NY, US
Assignee:
ALEXION PHARMACEUTICALS, INC - CHESHIRE CT
International Classification:
A61K 39/395, A61K 31/343, A61K 31/4439, A61K 31/245, A61P 9/10, A61K 38/17
US Classification:
4241351, 4241721, 4241331, 4241581, 514 209, 514278, 514535, 514469
Abstract:
The present disclosure relates to, inter alia, compositions containing an inhibitor of human complement and/or an inhibitor of interferon alpha, and the use of the compositions in methods for treating or preventing Degos' disease in a subject. In some embodiments, the inhibitor is an antibody, or antigen-binding fragment thereof, that binds to a human complement component C5 protein or to a biologically-active fragment of C5 such as C5a or C5b. In some embodiments, the inhibitor is an antibody, or an antigen-binding fragment thereof, that binds to interferon alpha or to an interferon alpha receptor.